Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand names Ozempic and Rybelsus) and chronic weight management (as Wegovy)
The recommended schedule of dosing is at night to mimic the effects of natural growth hormone release
Non-GLP-1 options: Other weight loss medications, structured programs, or metabolic surgery may be appropriate depending on your situation
Additionally, we find that the decrease in glutamate brought by acivicin could be rescued by administration of pyroglutamate (5-oxoproline), a downstream metabolite in the glutathione pathway that is a precursor of glutamate (Fig
Presentations at the ADA 85th Scientific Sessions in June 2025 looked at A1C reduction and weight loss across the five SURPASS trials
Pneumonia (Nathan Qld.) , 13 (1), 7